Extracellular Vesicle WNT5A as a Candidate Liquid Biopsy Biomarker in Soft Tissue Sarcoma
The Journal of Liquid Biopsy · 2026-11 · 13 · 100656
DOI: 10.1016/j.jlb.2026.100656 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Liquid Biopsy, 2026-11. Verfasst von Marina Pérez Capó und 7 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Introduction: Soft tissue sarcomas (STS) are rare and heterogeneous malignancies with a high risk of recurrence and limited biomarkers for longitudinal disease monitoring. Liquid biopsy offers a minimally invasive approach to assess tumour dynamics, yet clinically useful biomarkers for STS remain scarce. We investigated whether extracellular vesicle (EV)-associated WNT5A could serve as a candidate liquid biopsy biomarker for recurrence monitoring, while integrating transcriptomic and functional analyses to support its biological relevance.
Zitieren
APA
Capó, M. P., Font, E. M., Morillas, R. S., Perez, D. D. M., Rolfo, C., Vögler, O., Alemany, R., & Hevia, A. O. (2026). Extracellular Vesicle WNT5A as a Candidate Liquid Biopsy Biomarker in Soft Tissue Sarcoma. The Journal of Liquid Biopsy, 13, 100656. https://doi.org/10.1016/j.jlb.2026.100656
Vancouver
Capó MP, Font EM, Morillas RS, Perez DDM, Rolfo C, Vögler O, et al. Extracellular Vesicle WNT5A as a Candidate Liquid Biopsy Biomarker in Soft Tissue Sarcoma. The Journal of Liquid Biopsy. 2026;13:100656. doi:10.1016/j.jlb.2026.100656
BibTeX
@article{Cap2026,
author = {Capó, Marina Pérez and Font, Esther Martinez and Morillas, Raúl Sánchez and Perez, Diego de Miguel and Rolfo, Christian and Vögler, Oliver and Alemany, Regina and Hevia, Antònia Obrador},
title = {Extracellular Vesicle WNT5A as a Candidate Liquid Biopsy Biomarker in Soft Tissue Sarcoma},
journal = {The Journal of Liquid Biopsy},
year = {2026},
volume = {13},
pages = {100656},
doi = {10.1016/j.jlb.2026.100656}
}
EUVIMED